Coexpression cluster:C414

Full id: C414_cholangiocellular_testis_gall_pagetoid_mesothelioma_thyroid_osteoclastoma

Phase1 CAGE Peaks

Hg19::chr11:73874637..73874639,+	p@chr11:73874637..73874639 +
Hg19::chr11:77795673..77795689,-	p@chr11:77795673..77795689 -
Hg19::chr13:88008760..88008795,+	p@chr13:88008760..88008795 +
Hg19::chr13:98605781..98605792,+	p34@IPO5
Hg19::chr15:32969649..32969656,+	p14@SCG5
Hg19::chr15:32976526..32976537,+	p7@SCG5
Hg19::chr18:1099004..1099011,+	p@chr18:1099004..1099011 +
Hg19::chr18:514455..514467,+	p@chr18:514455..514467 +
Hg19::chr1:207059144..207059147,+	p@chr1:207059144..207059147 +
Hg19::chr21:45826350..45826387,+	p22@TRPM2
Hg19::chr2:158155402..158155409,-	p3@ENST00000410472
Hg19::chr2:158155450..158155474,-	p1@ENST00000410472
Hg19::chr2:234545393..234545403,+	p3@UGT1A10
Hg19::chr2:234545407..234545408,+	p9@UGT1A10
Hg19::chr2:234545437..234545446,+	p4@UGT1A10
Hg19::chr2:234545708..234545716,+	p5@UGT1A10
Hg19::chr3:98275000..98275016,-	p@chr3:98275000..98275016 -
Hg19::chr4:166513744..166513789,+	p@chr4:166513744..166513789 +
Hg19::chr4:166513830..166513834,+	p@chr4:166513830..166513834 +
Hg19::chr4:33469231..33469240,+	p@chr4:33469231..33469240 +
Hg19::chr5:52786654..52786665,-	p@chr5:52786654..52786665 -
Hg19::chr6:32522809..32522827,-	p@chr6:32522809..32522827 -
Hg19::chr6:32522832..32522842,-	p@chr6:32522832..32522842 -
Hg19::chr6:32549685..32549701,-	p13@HLA-DRB1
Hg19::chr7:91788143..91788146,-	p@chr7:91788143..91788146 -

Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

---

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

---

GO ID	GO name	FDR corrected p-value
GO:0047631	ADP-ribose diphosphatase activity	0.029669747316823
GO:0016486	peptide hormone processing	0.0346106294482937

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

---

Cell Type

Ontology term	p-value	n
metabolising cell	6.76e-18	12
endopolyploid cell	6.76e-18	12
parenchymal cell	6.76e-18	12
polyploid cell	6.76e-18	12
hepatocyte	6.76e-18	12

Uber Anatomy

Ontology term	p-value	n
intralobular bile duct	5.42e-195	1
acinus	5.42e-195	1
intrahepatic bile duct	5.42e-195	1
portal lobule	5.42e-195	1
hepatic acinus	5.42e-195	1
liver parenchyma	2.39e-66	3
liver lobule	2.39e-66	3
hepatic duct	2.39e-66	3
bile duct	4.27e-34	6
digestive system duct	4.27e-34	6
biliary system	2.62e-23	9
biliary tree	2.62e-23	9
biliary bud	2.62e-23	9
parenchyma	1.22e-14	15
liver	6.95e-12	19
duct	6.95e-12	19
digestive gland	6.95e-12	19
liver bud	6.95e-12	19
hepatic diverticulum	1.80e-10	22
liver primordium	1.80e-10	22
digestive tract diverticulum	4.42e-10	23
epithelial sac	2.15e-09	25
epithelium of foregut-midgut junction	2.15e-09	25
anatomical boundary	2.15e-09	25
hepatobiliary system	2.15e-09	25
foregut-midgut junction	2.15e-09	25
septum transversum	2.15e-09	25
sac	4.34e-09	26
exocrine gland	7.41e-08	31
exocrine system	7.41e-08	31
endocrine gland	4.03e-07	35

Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

---

Novel motifs

JASPAR motifs

Motifs	-log10(p-value)
{{{tfbs_overrepresentation_jaspar}}}

ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

---

No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

---

This analysis result is provided for C0 - C305 clusters.